middl
east
respiratori
syndrom
coronaviru
merscov
novel
zoonot
pathogen
infecti
outbreak
caus
merscov
saudi
arabia
spread
patient
countri
result
death
without
travel
histori
clinic
radiolog
featur
reliabl
differenti
mer
sar
real
world
compar
sar
mer
present
vagu
defin
epidemiolog
sever
symptom
higher
case
fatal
rate
review
summar
recent
find
field
merscov
especi
molecular
virolog
interspeci
mechan
clinic
featur
antivir
therapi
investig
diseas
newli
emerg
viru
mani
question
fulli
answer
includ
exact
mode
transmiss
chain
geograph
distribut
anim
origin
furthermor
new
protocol
need
launch
rapidli
evalu
effect
unproven
antivir
drug
vaccin
fasten
clinic
applic
new
drug
world
wit
devast
outbreak
sever
acut
respiratori
syndrom
coronaviru
sarscov
result
case
death
worldwid
sarscov
novel
zoonot
pathogen
caus
typic
fever
respiratori
symptom
specif
antivir
drug
vaccin
avail
sarscov
fortun
sarscov
remain
popul
month
vanish
without
trace
new
interspeci
coronaviru
outbreak
occur
saudi
arabia
infect
spread
countri
across
globe
infect
patient
result
death
march
viru
initi
design
hcovemc
individu
diagnos
middl
east
respiratori
syndrom
mer
link
directli
indirectli
one
four
countri
middl
east
therefor
viru
renam
middl
east
respiratori
syndrom
coronaviru
merscov
compar
sar
novel
coronaviru
emerg
vagu
defin
epidemiolog
sever
symptom
higher
case
fatal
rate
absenc
prophylact
therapeut
measur
importantli
circul
human
mix
featur
epidem
sporad
natur
largest
outbreak
merscov
outsid
saudi
arabia
occur
south
korea
confirm
case
death
includ
fourthgener
descend
mer
case
emerg
sporad
later
epidem
review
summar
recent
find
field
merscov
especi
molecular
virolog
interspeci
mechan
clinic
featur
antivir
therapi
well
specul
contain
cap
structur
along
poli
tail
compris
four
main
structur
protein
name
spike
membran
envelop
e
nucleocapsid
n
protein
protein
encod
within
end
viral
genom
viral
genom
organ
follow
order
tail
cap
structur
poli
tail
play
vital
role
replic
transcript
viral
genom
occupi
genom
encod
seri
nonstructur
protein
protein
involv
format
viral
replic
transcript
complex
glycoprotein
mediat
receptor
recognit
membran
fusion
also
focu
immun
strategi
merscov
glycoprotein
cleav
two
subunit
subunit
contain
receptorbind
domain
rbd
mediat
viral
attach
host
receptor
bind
receptor
subunit
chang
conform
partial
insert
target
cell
draw
viral
host
cell
surfac
closer
facilit
plasma
membran
fusion
conform
chang
requir
format
fusion
core
two
heptad
repeat
subunit
interfer
either
block
viral
entri
three
structur
protein
relat
virion
assembl
releas
merscov
contain
five
accessori
protein
name
fig
present
homolog
coronavirus
accessori
protein
exhibit
potent
antagonist
activ
interferon
respons
cytoplasm
nuclear
target
function
accessori
protein
yet
clarifi
accumul
evid
suggest
dromedari
camel
anim
reservoir
merscov
serolog
studi
shown
presenc
crossreact
antibodi
merscov
dromedari
camel
oman
qatar
mongolia
live
merscov
isol
directli
infect
camel
confirm
cameltohuman
transmiss
howev
exact
mode
transmiss
remain
larg
investig
effect
raw
meat
consumpt
intak
camel
milk
exposur
infect
remain
unclear
date
studi
found
regular
merscov
transmiss
exist
case
compar
analysi
indic
viru
isol
camel
show
genet
variat
genom
variant
infecti
human
find
partial
explain
lower
infect
rate
human
camel
therefor
camel
serv
import
reservoir
mainten
diversif
merscov
exist
intermedi
host
camel
human
yet
establish
sar
epidem
viru
transmiss
bat
human
intermedi
via
civet
paguma
larvata
spread
raccoon
specul
whether
merscov
transmit
similarli
given
evid
merscov
replic
cell
line
anim
includ
goat
pig
rabbit
hors
civet
howev
evid
intermedi
host
found
mediat
mer
transmiss
camel
human
origin
merscov
infect
camel
remain
unclear
transmiss
bat
support
follow
evid
merscov
phylogenet
close
relat
tylonycteri
bat
cov
pipistrellu
bat
cov
discov
tylonycteri
pachypu
pipistrellu
abramu
respect
hong
kong
reveal
merscov
genom
origin
bat
merscov
receptor
also
receptor
henc
show
function
ident
viral
gene
fragment
ident
quit
similar
merscov
also
recov
bat
howev
infecti
viru
isol
directli
bat
merscov
origin
directli
bat
spread
bat
human
explain
exact
mode
transmiss
geograph
distribut
origin
also
explain
initi
entri
viru
human
cell
mediat
specif
receptor
scientist
identifi
dipeptidyl
peptidas
also
known
function
receptor
merscov
wherea
sar
enter
target
cell
via
angiotensin
convert
enzym
membranebound
peptidas
type
ii
topolog
form
homodim
cell
surfac
contribut
critic
understand
pathogenesi
epidemiolog
newli
emerg
human
coronaviru
may
facilit
develop
antivir
therapi
vaccin
patient
chronic
obstruct
pulmonari
diseas
cystic
fibrosi
demonstr
increas
immunostain
alveolar
epithelia
alveolar
macrophag
find
suggest
preexist
pulmonari
diseas
increas
merscov
receptor
abund
predispos
individu
mer
morbid
mortal
consist
current
clinic
observ
merscov
enter
bodi
impair
innat
immun
respons
cell
includ
rigilik
receptor
signal
associ
express
interferon
addit
type
ii
major
histocompat
mhc
gene
affect
therebi
decreas
express
level
major
cytokin
involv
activ
lymphocyt
hostvir
interact
suggest
interspeci
transmiss
merscov
might
associ
follow
two
element
effici
infect
replic
vira
l
adsorpt
capac
surfac
human
cell
particularli
respiratori
epitheli
cell
inhibit
innat
immun
subsequ
viral
entri
human
cell
attenu
activ
adapt
immun
respons
take
host
metabol
apparatu
replic
effici
sever
outcom
mer
relat
gender
older
age
underli
diseas
major
mer
patient
elderli
male
median
age
year
studi
involv
patient
show
increas
casefat
rate
age
seven
younger
year
group
age
year
patient
age
year
older
studi
involv
consecut
patient
found
age
year
associ
increas
mortal
ci
p
patient
present
underli
comorbid
medic
disord
diabet
hypertens
patient
mer
present
symptom
influenzalik
ill
ili
clinic
mer
sar
show
similar
featur
includ
fever
cough
predominantli
dri
even
renal
failur
major
mer
patient
report
suffer
multipl
comorbid
condit
howev
mer
patient
show
fever
cough
present
walk
pneumonia
earli
stage
progress
rapidli
quarter
third
patient
show
digest
tract
symptom
half
patient
develop
acut
renal
impair
median
time
around
day
symptom
onset
case
requir
renal
replac
therapi
howev
patient
sar
show
acut
renal
failur
occur
day
onset
symptom
need
replac
therapi
possibl
factor
contribut
common
present
acut
renal
failur
mer
patient
includ
increas
number
chronic
renal
diseas
mer
patient
progress
respiratori
failur
direct
renal
injuri
present
renal
cell
merscov
detect
urin
without
travel
histori
link
patient
arabian
peninsula
known
mer
case
clinic
radiolog
featur
reliabl
differenti
mer
acut
pneumonia
caus
microbi
agent
asymptomat
case
report
among
femal
healthcar
worker
children
merscov
incid
children
less
frequent
seem
associ
less
mortal
patient
without
underli
comorbid
low
mortal
children
merscov
also
report
sarscov
infect
symptom
milder
without
mortal
hospit
merscov
shed
clarifi
new
epidem
korea
hospit
first
week
day
day
onset
symptom
viabl
viru
shed
respiratori
secret
clinic
fulli
recov
patient
sar
viral
load
upper
respiratori
tract
secret
low
first
day
ill
increas
progress
peak
earli
second
week
result
emphas
need
suffici
isol
base
laboratori
result
rather
sole
clinic
symptom
patient
coronaviru
infect
date
approv
antivir
therapi
avail
merscov
indic
much
slower
respons
potenti
pandem
avian
flu
candid
antivir
agent
identifi
use
three
gener
approach
first
broadspectrum
antivir
drug
interferon
ribavirin
cyclophilin
inhibitor
effect
sar
patient
determin
test
activ
merscov
vitro
studi
suggest
type
interferon
exert
antivir
effect
sever
cell
line
merscov
time
time
sensit
interferon
ifn
treatment
sarscov
vitro
studi
also
show
signific
antivir
effect
ribavirin
interferon
combin
therapi
retrospect
studi
ribavirin
interferon
therapi
significantli
associ
improv
surviv
day
day
clinic
signific
cyclosporin
mer
treatment
like
limit
drug
peak
serum
level
clinic
dosag
merscov
second
approach
identifi
candid
antivir
target
mer
involv
screen
chemic
librari
compris
numer
exist
drug
advantag
approach
includ
commerci
avail
known
pharmacokinet
establish
safeti
report
first
drug
identifi
approach
mycophenol
acid
antireject
drug
use
transplant
broadspectrum
antivir
drug
drug
merscov
low
therefor
low
dosag
may
effect
without
induc
signific
immunosuppress
assumpt
warrant
preclin
evalu
anim
studi
drug
includ
lopinavir
chloroquin
still
remain
vitro
stage
third
approach
antivir
drug
develop
base
knowledg
genom
structur
biolog
merscov
compar
drug
identifi
first
second
approach
identifi
approach
effect
merscov
howev
novel
drug
develop
need
time
invest
therapeut
potenti
antibodi
target
coronavirus
well
recogn
sar
outbreak
date
monoclon
antibodi
target
differ
epitop
rbd
subunit
merscov
protein
identifi
monoclon
antibodi
bind
rbd
higher
affin
rbd
bind
affin
human
confer
broader
higher
neutral
activ
one
antibodi
neutral
viru
except
potenc
therefor
repres
potenti
drug
vaccin
candid
synthet
peptid
deriv
domain
merscov
spike
protein
specif
bind
domain
viral
spike
protein
block
viral
fusion
result
inhibit
merscov
replic
spike
proteinmedi
cell
fusion
nevertheless
major
obstacl
relat
difficulti
gener
highli
potent
neutral
mab
rel
short
time
epidem
challeng
relat
emerg
possibl
escap
mutant
outbreak
merscov
pose
seriou
threat
global
public
health
highlight
imper
investig
viral
epidemiolog
pathogenesi
well
develop
effect
therapeut
prophylact
agent
merscov
infect
first
welldesign
largescal
casecontrol
studi
need
defin
transmiss
chain
merscov
enabl
appropri
intervent
govern
second
retrospect
serum
antibodi
detect
continu
defin
true
distribut
human
anim
third
systemat
surveil
sign
host
adapt
viral
genom
variat
import
fourth
random
control
studi
conduct
evalu
effect
avail
antivir
drug
final
anim
vaccin
limit
animaltohuman
transmiss
alter
approach
drug
develop
newli
emerg
infecti
diseas
howev
regard
clinic
trial
note
tradit
sequenc
studi
anim
follow
phase
clinic
trial
may
slow
public
health
emerg
common
protocol
launch
rapidli
evalu
promis
unproven
therapi
current
fatal
emerg
infecti
diseas
outbreak
futur
epidem
